Glaxo: FDA OKs Advair 250/50 to reduce exacerbations in COPD patients | 30 Apr 08, 22:42

Home | Support

Headline News:

Drug Testing

Glaxo: FDA OKs Advair 250/50 to reduce exacerbations in COPD patients

30 Apr 08, 22:42

SAN FRANCISCO (Thomson Financial) - GlaxoSmithKline late Wednesday said the Food and Drug Administration has approved its Advair Diskus 250/50 for the ...

more